Pharmaceutical Maker Novo Nordisk Suffers Ransomware Attack

Despite a cyberattack at Novo Nordisk A/S that forced the company to shut down some systems, its core business operations remain up and running.
To that end, Novo Nordisk, the maker of weight-loss drug Wegovy, said Thursday, June 11, it identified an IT security incident involving unauthorized access to a limited number of internal IT systems.
“Upon learning of the incident, we launched an investigation with the assistance of external cybersecurity experts, and we are in contact with the relevant authorities,” the company said in an advisory.

Estimated Cost

Unknown at this time

Threat Source

Impacts

IT